Clinical Trial Update: Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab

View source ↗

Summary

A completed clinical trial update on patients with low-grade Non-Hodgkin lymphoma treated with iodine-131 labeled tositumomab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Bexxar (tositumomab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lymphoma, Non-Hodgkin | Status: COMPLETED